Tag

#approved

Diseases
Keytruda (pembrolizumab) is approved for cancer solid tumors
Keytruda Keytruda (pembrolizumab) is indicated for the treatment of adult and pediatric patients with unresectable or metastatic solid tumors that have been identified as having a biomarker referred to as microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). Indications Metastatic Melanoma. Unresectable Melanoma. Refractory, metastatic Non-small cell lung cancer. Keytruda mechanism of Action Keytruda works…
May 23, 2017
News & Updates
Bavencio approved by FDA for metastatic Merkel cell carcinoma (MCC)
“While skin cancer is one of the most common cancers, patients with a rare form called Merkel cell cancer have not had an approved treatment option until now,” said Richard Pazdur, M.D., acting director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research and director of the…
Mar 23, 2017